Segall Bryant & Hamill’s Acadia Healthcare ACHC Stock Holding History

Segall Bryant & Hamill’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.8M	Buy	+468,207	New	+$12M	0.16%	205
2023 Q3	–	Sell	-3,000	Closed	-$239K	–	506
2023 Q2	$239K	Hold	3,000	–	–	﹤0.01%	662
2023 Q1	$216K	Hold	3,000	–	–	﹤0.01%	688
2022 Q4	$246K	Hold	3,000	–	–	﹤0.01%	674
2022 Q3	$234K	Sell	3,000 -1,500	-33%	-$120K	﹤0.01%	683
2022 Q2	$303K	Buy	+4,500	New	+$314K	﹤0.01%	662
2020 Q2	–	Sell	-10,289	Closed	-$189K	–	774
2020 Q1	$189K	Sell	10,289 -1,500	-13%	-$42.9K	﹤0.01%	745
2019 Q4	$392K	Hold	11,789	–	–	0.01%	692
2019 Q3	$367K	Sell	11,789 -983	-8%	-$29.9K	0.01%	702
2019 Q2	$445K	Sell	12,772 -2,166	-14%	-$70K	0.01%	680
2019 Q1	$439K	Sell	14,938 -3,734	-20%	-$106K	0.01%	680
2018 Q4	$480K	Sell	18,672 -25,896	-58%	-$896K	0.01%	653
2018 Q3	$1.57M	Sell	44,568 -211	-0.5%	-$8.41K	0.02%	478
2018 Q2	$1.83M	Buy	44,779 +23,427	+110%	+$945K	0.03%	443
2018 Q1	$837K	Hold	21,352	–	–	0.02%	370
2017 Q4	$697K	Hold	21,352	–	–	0.02%	376
2017 Q3	$1.02M	Buy	21,352 +65	+0.3%	+$3.17K	0.02%	355
2017 Q2	$1.05M	Hold	21,287	–	–	0.02%	358
2017 Q1	$928K	Sell	21,287 -500	-2%	-$20.3K	0.02%	353
2016 Q4	$721K	Sell	21,787 -1,889	-8%	-$73.3K	0.02%	381
2016 Q3	$1.17M	Buy	23,676 +10,026	+73%	+$522K	0.03%	337
2016 Q2	$756K	Hold	13,650	–	–	0.02%	378
2016 Q1	$752K	Buy	13,650 +150	+1%	+$8.56K	0.02%	377
2015 Q4	$843K	Hold	13,500	–	–	0.02%	353
2015 Q3	$895K	Hold	13,500	–	–	0.02%	356
2015 Q2	$1.06M	Hold	13,500	–	–	0.02%	345
2015 Q1	$967K	Hold	13,500	–	–	0.02%	346
2014 Q4	$826K	Hold	13,500	–	–	0.02%	370
2014 Q3	$655K	Hold	13,500	–	–	0.02%	396
2014 Q2	$614K	Sell	13,500 -14,000	-51%	-$615K	0.01%	404
2014 Q1	$1.24M	Hold	27,500	–	–	0.03%	311
2013 Q4	$1.3M	Hold	27,500	–	–	0.03%	308
2013 Q3	$1.08M	Sell	27,500 -7,100	-21%	-$264K	0.03%	320
2013 Q2	$1.14M	Buy	+34,600	New	+$1.12M	0.03%	296

Other funds holding ACHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CCM

Carronade Capital Management Darien, Connecticut $5.77B AUM 89.67% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.05B AUM 71.03% 1-Year Est. Return

Segall Bryant & Hamill's ACHC Position: Q2 2026 in Review

Segall Bryant & Hamill opened a new position in Acadia Healthcare (ACHC) in Q2 2026: 468,207 shares worth $13.8M. The stake represents 0.16% of the portfolio and ranks #205 among its holdings. This is a return to the name: Segall Bryant & Hamill previously reported a position in ACHC as recently as Q2 2023.

Segall Bryant & Hamill first reported a position in ACHC in Q2 2013 and has held it in 34 quarters since. 314 funds tracked by Wall St. Rank hold ACHC as of Q2 2026.

Segall Bryant & Hamill held 468,207 shares of Acadia Healthcare worth $13.8M as of Q2 2026.
Acadia Healthcare was a new Segall Bryant & Hamill position in Q2 2026.
Acadia Healthcare made up 0.16% of Segall Bryant & Hamill's portfolio in Q2 2026, its #205 holding.
Segall Bryant & Hamill first reported a position in Acadia Healthcare in Q2 2013 and has held it in 34 quarters since.
314 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.